ASPEN ch 17 - PN complications Flashcards

1
Q

categories of PN complications?

A

mechanical, metabolic, infectious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common complication associated with PN

A

hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

why hyperglycemia?

A

stress associated, excess CHO admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

recommend target BG concentration between _____ mg/dL

A

140-180

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PN should be initiated at ___ of estimated energy needs for first 24 hrs

A

half

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CHO admin NOT exceed rate of _____mg/kg/min or ____kcal/kg/d in acutely ill

A

4-5; 20-25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

giving subsequent dose of insulin too soon is referred to as:

A

stacking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

rare reason for hyperglycemia?

A

chromium deficiency (makes insulin less effective)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

hyperglycemia associated with these worsened clinical outcomes:

A

^ risk infection, poor healing, inability gain wt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

why hypoglycemia?

A

excess insulin admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

abrupt PN d/c associated with:

A

rebound hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how to prevent rebound hyperglycemia?

A

1-2hr taper down of infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

clinical manifestation of EFAD?

A

scaly dermatitis, alopecia, hepatomegaly, thrombocytopenia, fatty liver, anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

a triene:tetraene ratio > ___ indicates EFAD

A

0.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why PN need exogenous source of fat?

A

hypertonic dextrose infusion causes insulin secretion and reduction in lipolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

__ based ILEs associated with immunosuppressive effects, exaggerated SIRS, reticuloendothelial system dysfunction

A

soy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how come certain LCFA impaire immune fxn?

A

interfere w/ phagocytosis and chemotaxis, ^ risk for infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how does hypertriglyceridemia occur?

A

dextrose overfeeding or rapid admin rates ILE > 0.11g/kg/h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

probs of hyperlipidemia?

A

impaire immune response, alter pulmonary hemodynamics, ^ risk pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ILE intake should be restricted to < ___% energy or ___g/kg/d

A

30; 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

pancreatitis due to ILE hyperlipidemia rare unless serum TG > ___mg/dL

A

1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

when pro admin excess, metabolic demand of disposing of byproducts of pro metabolism ^, thus ___ can result

A

azotemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

prerenal azotemia result from:

A

dehydration, excess pro, inadequate nrg from nonpro sources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

intolerance to protein load is characterized by____

A

^BUN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
crystalline a.a. prevents ___ risk
hyperammonemia
26
why pt receiving both PN and warfarin need close monitoring?
vit K in the preparation interacts with warfarin -->therapeutic failure
27
pt with hx prolonged poor diet intake should have supplemental __ and __
thiamine; folic acid
28
vitamin that undergo degradation after addition to PN?
vit A
29
trace element deficiencies that may occur?
zinc, selenium
30
decrease ____ dosing in pt with hepatobiliary disease cuz impairs excretion
copper; manganese
31
adverse effects of metabolic and physio shifts of fluid/electrolytes/vit/min in aggressive nutr support or repletion of malnourished pt
refeeding syndrome
32
at refeeding risk ___ days after start of support
2-5
33
mechanism of refeeding?
reintroduction of CHO cause insulin release which uptakes lots of gluc/lytes/min/water to cells, CHO admin increases demand for intracell P to synth ATP (v P), ^ need for thiamine/K/Mg
34
why liver disease common in PN?
intestinal failure
35
3 types of hepatobiliary disorders associated with PN:
steatosis, cholestasis, gallbladder sludge/stones
36
what is steatosis?
hepatic fat accumulation
37
steatosis presents as modest elevations of serum ___
aminotransferase
38
condition of impaired secretion of bile or frank biliary obstruction that occurs predominantly in children
PNAC (PN-associated cholestasis)
39
PNAC typically presents as:
elevated alkaline phosphates, gamma-glutamyl transpeptidase, conjugated bilirubin [ ] w/ jaundice
40
elevated serum ))) considered prime indictator for cholestasis
conjugated bilirubin
41
gallbladder stasis during PN may lead to development of _____ with subsequent ____
gallstones/sludge; cholecystitis
42
gallbladder stasis has more to do with ____ than PN infusion
lack of enteral stim (v CCK and impaired bile flow)
43
biliary sludge may progress to ____ in the absence of gallstones, referred to as ____ cholecystitis
acute cholecystitis; acalculous
44
infection associated with ____
cholestasis
45
risk factors for liver disease:
SIBO, massive resection of intestine
46
development of steatosis in PN primarily cuz of:
excess nrg (promote hepatic fat deposition by stim insulin release, ^ lipogenesis and v f.a. oxidation)
47
why dextrose-based PN containing little/no fat implicated in steatosis?
excess CHO deposit as fat, and may result in EFAD which lead to impaired lipoprotein formation and TG secretion
48
CHO content not exceed ____g/kg/d for adults
7
49
high lvl ___ exposure may lead to develop cholestasis
aluminum
50
probs of phytosterols/
inefficiently metabolized, impaire bile flow and cause sludge/stones
51
primary ___ deficiency associated with steatosis
carnitine
52
why maybe supplement choline?
conversion of methionine to choline may be less efficient when methionine given PN instead of PO
53
this type of PN shown reduce serum liver enzyme and conjugated bilirubin
cyclic
54
form of bile acid used to treat various chronic cholestatic liver diseases
ursodiol
55
most common form of metabolic bone disease characterized by low bone mass, compromised bone strength, deterioration of bone tissue/architecture
osteoporosis
56
___ is characterized by softening/bending of bones that occurs cuz bones contain osteoid tissue that failed to calcify
osteomalacia
57
risk factors for bone loss?
post menopause, long term PN, endocrine disease, GI disease, malignancy, meds, genetic disease, immobilization, alcohol, anorexia nervosa, roux en y
58
calcium supplementation in PN limited by minerals' physical compatibility with ___
P
59
inadequate ___ dose may ^ urinary Ca excretion
P
60
higher ___ doses associated ^ urinary Ca excretion
protein
61
correction of acidosis with ___ in PN can reduce urinary calcium excretion
acetate
62
cyclic or continuous more Ca losses?
cyclic
63
why vit D excess cause bone disease?
suppress PTH secretion and promote bone resorption
64
only allowed to have up to ___mcg aluminum/L
25
65
___ is a prominent manifestation of Mg deficiency
hypocalcemia
66
Mg deficiency results in v mobilization of Ca from bone thru these mechanisms:
^ release mg ions at bone surface in exchange for ^ bone uptake of Ca ions from serum; inhibit PTH release, so low PTH lvls for degree of hypocalcemia, functional v bone response to PTH so functional hypoparathyroidism
67
magnesium deficiency can lead to hypophosphatemia how?
^ P excretion
68
copper deficiency can impair ___ formation, causing ____
bone; osteoporosis
69
meds that decrease bone resorption:
bisphosphonates, raloxifene, calcitonin, estrogen, monoclonal antibody denosumab
70
only FDA approved med that stim bone formation
teriparatide
71
avoid adding ___ to reduce osteoporosis risk
heparin
72
most common deficiencies
selenium, linoleic acid, Zn, Cu, Chromium, fat/water sol vitamins
73
symptoms o hypophosphatemia:
parasthesia, muscular weakness, confusion, convulsions, coma